load

Instruction for Use of Valenta Pharm’s Medicine to Treat Gastrointestinal Disorders Was Changed

Instruction for Use of Valenta Pharm’s Medicine to Treat Gastrointestinal Disorders Was Changed

10.04.2019

The instruction for use Exportal® produced by Valenta Pharm was complemented with new data regarding its pharmacologic features and dosage.

The part ‘Pharmacologic features. Pharmacodynamics’ of the Exportal® Instruction for use was changed. It was complemented with an explanation that the prebiotic effect of lactitol (the active pharmaceutical ingredient of Exportal®) stimulating the growth of its own “beneficial” intestinal bacteria and simultaneously suppressing “unhealthy” bacteria, is an action that restores its own intestinal microbiome1, which is extremely important for the organism.

Another change was made in the part the Instruction for use ‘Way of use and dosage'. Half-dosages of the drug for adults and children are described in detail, which is especially important for individual dosing and achieving the desired effect - prebiotic or laxative1.

Valenta Pharm constantly develops its products, carefully studies the needs of doctors and patients, and offers innovative approaches to solve medical problems, thereby improving the quality of life for people.

“These changes were made primarily for the convenience of patients in the selection of individual dosages and achieving results: the return of ease and regular bowel movement, the restoration of the individual microbiome”, - mentioned Aleksey Posokhin, product manager of the Gastrointestinal Department at Valenta Pharm.

  • 1 Exportal® Instruction for Use (ЛСР-003898/07).